Early feasibility studies on climate-friendly albuterol inhaler completed

FHS
May 11, 2024
12:25 pm

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable performance to Ventolin® HFA but with a significant reduction in greenhouse gas emissions.

Evaluate, a Norstella company, announces acquisition of J+D Forecasting

J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry, is excited to officially share the news of our acquisition by Evaluate, a

January 15, 2024

Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments – Biotech Investments

EQS-News: Eckert & Ziegler SE / Key word(s): Incoming Orders/Alliance Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation

December 6, 2024

Medmo Secures $9M to Streamline Medical Imaging

What You Should Know: Medical imaging technology company Medmo announced a $9 million funding round led by Lerer Hippeau,alongside existing investors Jerusalem Venture Partners (JVP), C2 Ventures and Stone IsraVentures. In

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.